To investigate the function of the pa4079 gene from the opportunistic pathogen Pseudomonas aeruginosa PAO1, we determined its crystal structure and confirmed it to be a NAD(P)-dependent short-chain dehydrogenase/reductase. Structural similarity and activity for a broad range of substrates indicate that PA4079 functions as a carbonyl reductase. Comparison of apo-and holo-PA4079 shows that NADP stabilizes the active site specificity loop, and small molecule binding induces rotation of the Tyr183 side chain by approximately 90°out of the active site. Quantitative real-time PCR results show that pa4079 maintains high expression levels during antibiotic exposure. This work provides a starting point for understanding substrate recognition and selectivity by PA4079, as well as its possible reduction of antimicrobial drugs.
To investigate the function of the pa4079 gene from the opportunistic pathogen Pseudomonas aeruginosa PAO1, we determined its crystal structure and confirmed it to be a NAD(P)-dependent short-chain dehydrogenase/reductase. Structural similarity and activity for a broad range of substrates indicate that PA4079 functions as a carbonyl reductase. Comparison of apo-and holo-PA4079 shows that NADP stabilizes the active site specificity loop, and small molecule binding induces rotation of the Tyr183 side chain by approximately 90°out of the active site. Quantitative real-time PCR results show that pa4079 maintains high expression levels during antibiotic exposure. This work provides a starting point for understanding substrate recognition and selectivity by PA4079, as well as its possible reduction of antimicrobial drugs.
Database
Structural data are available in the Protein Data Bank (PDB) under the following accession numbers: apo PA4079 (condition I), 5WQM; apo PA4079 (condition II), 5WQN; PA4079 + NADP (condition I), 5WQO; PA4079 + NADP (condition II), 5WQP.
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The opportunistic pathogen Pseudomonas aeruginosa is linked with acute and chronic infections in humans and poses particularly high risks for cystic fibrosis (CF) patients [1] [2] [3] . Pseudomonas aeruginosa undergoes phenotypic and genetic adaptation to the environment during long-term chronic lung infections in CF, and the crucial step in persistence in the host is biofilm formation [4, 5] . Persistent P. aeruginosa forms adopt characteristic traits including antimicrobial resistance [6, 7] , resistance to phagocytosis [8] and reduced virulence [9] .
Pseudomonas aeruginosa is resistant to antimicrobials via several mechanisms, including mutations to change antibiotic targets, outer membrane efflux proteins to evict antibiotics, and production of antibody-degrading or inactivating enzymes [10] . Challenges presented by high levels of antimicrobial resistance indicate an urgent need for more effective strategies and treatments against P. aeruginosa infection.
The Pseudomonas Genome database (www.pseud omonas.com) categorizes the pa4079 gene as encoding Abbreviations AUC, Analytical ultracentrifugation; CF, cystic fibrosis; DMSO, dimethyl sulfoxide; PA, adenine phosphate; PEG, polyethylene glycol; PN, nicotinamide phosphate; SSRF, Shanghai Synchrotron Radiation Facility. a putative short-chain dehydrogenase/reductase (SDR) based on conserved sequence motifs and a proposed NAD(P)H-binding site [11] . The SDR family is one of the largest protein families and consists of enzymes with great functional diversity and low pairwise sequence identity [12] . Most SDR enzymes are NAD (P)-dependent and typically range from 250 to 300 residues. In humans, SDR enzymes metabolize a large variety of compounds including steroid hormones, prostaglandins, retinoids, lipids and xenobiotics. All carbonyl reductases belong to the SDR family and catalyse the reduction of various carbonyl and quinone compounds to their respective alcohol and quinol products in an NAD(P)H-dependent manner. Carbonyl reductases share two highly conserved amino acid sequence motifs: an S-YXXXK motif in which the conserved tyrosine performs a key catalytic function, and a GXXXGXG motif located near the NAD (P)H-binding site.
In this study, we report structures of apo PA4079 in two different crystal forms to 2.6 A and 2.0 A. We also report structures of the holo form of PA4079 with bound NADP cofactor from two different crystallization conditions to 1.78 A and 1.7 A respectively. Structural analysis confirms that PA4079 belongs to the short-chain dehydrogenase/reductase (SDR) family, with close structural homology to a number of eukaryotic carbonyl reductases. NADP binding induces structural changes including the ordering of the active site specificity loop, and the presence of small molecules in the active site induce a 90°rotation of the Trp183 side chain out of the substrate-binding site. Enzymatic analysis using a range of substrates shows that PA4079 has broad activity for carbonyl compounds including quinones, ketones and aliphatic aldehydes, suggesting it functions as a carbonyl reductase. Quantitative real-time PCR (qPCR) analysis shows that pa4079 maintains a high level of expression during antibiotic exposure. The work presented here should provide a starting point for further investigation of the role of PA4079 in the metabolic process of carbonyl compounds in P. aeruginosa.
Materials and methods

Plasmid construction
The pa4079 gene was amplified from the genome of P. aeruginosa PAO1 (kindly provided by Prof. Lei Wang, Nankai University) by polymerase chain reaction. The forward primer sequence was as follows: 5 0 -CGGGATCC ATGCACAACGTTCTGATCG-3 0 , containing a BamHI restriction site. The reverse primer sequence, including a XhoI restriction site, was as follows: 5 0 -CCGCTCGAGT CACCAGGGCAGCG-3 0 . The PCR product was purified and digested with BamHI and XhoI. Digested PCR products encoding PA4079 were cloned into the vector pGEX6p-1 (GE Healthcare, Beijing, China). The constructed pGEX-6p-PA4079 plasmid was then used as a template to generate S135A/Y151F/K155M/W183A mutations using a fast-mutagenesis system (TransGen, Beijing, China).
Protein expression and purification
For PA4079 expression, Escherichia coli BL21(DE3) strains were grown in Luria-Bertani broth medium containing 100 lgÁmL À1 ampicillin at 37°C. When the OD 600 reached 0.6, IPTG was added to the growth medium to a final concentration of 0.5 mM to induce expression of recombinant proteins. The induced cultures were grown at 16°C for 16 h. The cells were harvested by centrifugation, resuspended in lysis buffer (50 mM Tris, 500 mM NaCl, 10% glycerol, pH 8.0) and then lysed by sonication on ice. Cell debris was removed by centrifugation at 18 000 g for 40 min at 4°C. The supernatant was loaded on to an GST column (GE Healthcare) equilibrated with lysis buffer. The column was washed extensively with lysis buffer. Finally, 0.6 mg PreScission Protease (GE Healthcare) was added to the resin to remove the GST-tag. The protein was eluted with 20 mM Tris, pH 8.0, then concentrated and purified using anion-exchange chromatography on a Hitrap Q column (GE Healthcare). The protein was further purified using a Superdex75 column (GE Healthcare) equilibrated with 20 mM Tris, 200 mM NaCl, pH 8.0. The purified protein was concentrated to 5 mgÁmL À1 and stored in a buffer containing 20 mM Tris, 200 mM NaCl, pH 8.0 for crystallization.
Crystallization
Crystallization of purified PA4079, including additional residues -GPLGS -at the N-terminal following GST-tag removal, was performed by the sitting-drop vapour-diffusion method at 293K. We utilized Crystal Screen kits from Hampton Research for screening. Regular crystals of the native protein were observed after 2 weeks in a reservoir consisting of 4M sodium formate. Native crystals were also obtained from a second condition consisting of 0.2 M ammonium acetate, 0.1 M Bis-Tris pH 5.5, 25% w/v polyethylene glycol (PEG) 3350.
To form a NADP complex, the protein was mixed with NADP-Na2 at 4°C overnight. Complex crystals were obtained under two conditions. The first condition consisted of 0.2 M ammonium acetate, 0.1 M sodium acetate trihydrate, pH 5.6, 30% PEG 4000. The second condition consisted of 1.26M sodium phosphate monobasic monohydrate, 0.14M potassium phosphate dibasic, pH 5.6.
Data collection and structure determination
Prior to data collection, crystals were cryoprotected by adding 20% glycerol to the crystallization buffer before being flash-cooled in liquid nitrogen. Apo-PA4079 diffraction data sets were collected on beamline 1A of the Photon Factory (KEK, Tsukuba, Japan) and beamline 19U of the Shanghai Synchrotron Radiation Facility (SSRF, Shanghai, China) at 100 K. Data sets were integrated, scaled and merged using the HKL2000 suite [13] . Data for the PA4079-NADP complexes were collected on beamline 19U of the SSRF at 100K.
The native PA4079 structure was determined by molecular replacement with PHASER [14] in the PHENIX suite [15] using PDB entry 3WXB (sequence identity: 27%) as a search model. The model was edited using Sculptor and a solution was found with 4 molecules per asymmetric unit. The structure was refined in PHENIX [15] combined with cycles of manual building in COOT [16] . A second structure of native PA4079, also with four molecules per asymmetric unit, was determined from a second crystallization condition by PHASER [14] in the PHENIX [15] suite using the PA4079 model as a search model. NADP-bound PA4079 complex structures were determined by molecular replacement with PHASER [14] in the PHENIX [15] suite using the PA4079 structure as a search model and refined in PHENIX [15] combined with cycles of manual building in COOT [16] . The NADP cofactor and ligands were manually fitted into difference electron density maps using COOT [16] during the later stages of refinement. All structures were validated with MOLPROBITY [17] . All structures were visualized using PYMOL (www.pymol. org).
Analytical ultracentrifugation
Analytical ultracentrifugation (AUC) was performed using a Beckman Coulter ProteomeLab XL-I analytical ultracentrifuge with two-channel centrepieces and sapphire windows at 142 000 g and 277K with UV. For the assay, we used a purified protein solution (400 lL, 1 mgÁmL À1 ) in loading buffer containing 20 mM Tris, 200 mM NaCl, pH 8.0. The data were analysed using SEDFIT [18] .
Activity assays
Enzyme activity assays were performed at 25°C. The reaction mixture contained 150 mM sodium phosphate pH 7.0, 0.12 mM NADPH, 0.001-2.4 mM substrates and the concentration of enzyme was 0.005 lgÁlL
À1
. Substrates were dissolved in 40% ethanol. The final concentration of the ethanol in the enzyme activity assay system was lower than 1%. A Synergy 4 spectrophotometer (BioTek, Winooski, VT, USA) was used to monitor the absorbance of NADPH at 340 nm (extinction coefficient e = 6.19 mM À1 Ácm À1 ).
Bacterial strains, stress conditions
Pseudomonas aeruginosa PAO1 bacterial cells from a single colony were grown in 80 mL 50% LB medium for 12 h at 37°C in an 180 rpm shaking incubator. After the bacterial cell count reached 10 8 cellsÁmL
À1
, they were divided into four flasks: two flasks without treatment as control (1 and 
Flow cytometry
The number of total and intact bacterial cells was deter- 
RNA extraction
Total RNA were extracted using the Total RNA Purification kit (Gene Mark, Beijing, China). Pseudomonas aeruginosa PAO1 cells were harvested by centrifugation (2000 g, 2 min). Samples were then treated according to the manufacturer's instructions and stored at À70°C. RNA concentrations were measured using a NanoDrop ultraviolet spectrophotometer (Thermo Scientific, Beijing, China) with absorbance at 260 nm.
Real-time qPCR
To reduce the contamination risk of RT-qPCR analysis, real-time PCRs were carried out using a one-step RTqPCR Kit (SYBR Green with low ROX; Gene Mark) in 96-well plates. Before the experiment, the pa4079 gene and 16S RNA primers were diluted 8 times and 40 times respectively. The sequences for the forward and reverse primers for pa4079 are 10 lL of 2 9 RT-qPCR reaction kit, 1 lL of RNA template, 0.8 lL of primers and 7.2 lL of Rnase-free water) was used. In each run, negative controls were included. The qPCR experiments were performed using a LightCycler 96 instrument (Roche, Shanghai, China). Typical cycling parameters were designed as follows: reverse transcription at 50°C for 3 min, initial denaturation at 95°C for 10 min, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s. The fluorescence values were measured during each annealing step. The melting curve was used to verify the specificity of the real-time PCR reaction. A threshold cycle value (C T ) was determined in each measurement. C T is defined as the number of cycles necessary to reach the given threshold in which the fluorescent signal is first recorded significantly. Results were analysed using the 16S RNA as a reference [19] :
Results and Discussion
Crystal structure of PA4079
Crystal structures of PA4079 were determined in both the apo form and holo form with the NADP cofactor. Apo PA4079 was crystallized in two different crystal forms: in P 4 1 2 2 to 2.60 A resolution (crystal form I), and in P 2 1 2 1 2 1 to 2.0 A resolution (crystal form II). The structure of PA4079 was resolved by molecular replacement using PDB entry 3WXB (sequence identity: 27%) as a search model. PA4079, which has a molecular mass of 24 kDa, eluted as a dimer in gel filtration chromatography and exhibited a single peak at 44 kDa by analytical ultracentrifugation, consistent with a homodimer (Fig. 1A) . Both apo PA4079 structures feature four molecules in the crystal asymmetric unit, corresponding to two PA4079 dimers (Fig. S1 ). The two homodimers are almost identical when superimposed with an r.m.s.d. of 0.4
A. In both apo structures, the polypeptide chains are complete except for residues 182-195 which are not visible. No presence of a cofactor was detected during refinement of the crystal structures. All data collection and refinement statistics are summarized in Table 1 .
Each PA4079 monomer contains a large central b-sheet of seven b-strands that is flanked by three a-helices on one side and four a-helices on the other, forming a sandwich structure (Fig. 1B) . Helices a1-a4, a7 and strands b1-b6 form the N-terminal NADPbinding domain, while helices a5, a6 and strand b7 form the C-terminal domain that mediates catalytic activity (Fig. 1B) . Dimerization of PA4079 is mediated by helices a5 and a6 in the C-terminal domain, which form a helical bundle with their counterparts from the neighbouring monomer. The loop between strand b4 and helix a4 and the loop between strand b5 and helix a6 also contribute to the dimerization of PA4079, which has an interface area of 1400 A 2 ( Fig. 1C,D) .
PA4079 is a carbonyl reductase
A Dali search [20] A for 192 aligned residues; 21% sequence identity). All structures share a common fold and mode of NADP binding despite low sequence identity ( Fig. 2A,B) . Multiple sequence alignment confirms the low sequence identity between PA4079 and its structural homologues, but identifies the conserved S-YXXXK and GXXXGXG motifs consistent with members of the SDR family (Fig. 3) .
We next sought to investigate whether PA4079 also possesses carbonyl reductase activity. Our activity assays show that PA4079 can reduce a broad range of carbonyl compounds including quinones, ketones and aldehydes (Table 2 ). PA4079 reduced all carbonyl compounds tested except for p-nitroacetophenone, tropinone, estrone and 4-benzoylpyridine, for which no activity was detected. PA4079 most efficiently utilized 9,10-phenanthrenequinone with a k cat of 48 9 10 2 min
À1
and showed modest activity for 1,4-benzoquinone, phenylglyoxal monohydrate and p-nitrobenzaldehyde. This is in good agreement with D. melanogaster, porcine and human carbonyl reductases which all have efficient activity for 9,10-phenanthrenequinone but modest activity for p-nitrobenzaldehyde and other substrates [21] .
Structure of PA4079 bound to NADP
As no endogenous NADP was observed in the apo structure, a PA4079-NADP complex was prepared by adding NADP-Na2 to the PA4079 protein in a 3 : 1 molecular ratio and incubating overnight at 4°C prior to crystallization. Crystals were obtained under two distinct conditions, both belonging to the space group P 2 1 2 1 2 1 and with similar unit cell parameters. Data sets were collected to 1.78 A for crystals from condition I, and to 1.70 A resolution for crystals from condition II (Table 1 ). The PA4079-NADP structures were determined by molecular replacement using the apo-PA4079 monomer structure as a search model. Each asymmetric unit of the PA407-NADP crystals contains one PA4079 dimer, of which only one monomer binds an NADP molecule that is clearly defined in electron density ( Figs 1D, 4A,B) . All PA4079 residues were visible from electron density and are included in the final models.
The NADP-bound structures do not show any dramatic conformational changes compared to the apo PA4079 structure (Fig. 1C,D) . A holo PA4079 dimer can be superimposed onto an apo PA4079 dimer with an r.m.s.d. of 0.54 A for 437 aligned residues. One major difference concerns the loop connecting helix a6 and strand b4 (residues 181-196), which is only visible in the holo form suggesting that it is stabilized by NADP binding. Other notable changes include the side chain of Trp183 rotating by almost 90°out of the active site in the NADP-bound structures, with the space of the Trp183 side chain instead occupied by small molecules (see below) (Fig. 4) .
The adenine ring of NADP forms a hydrogen bond with the main chain amide group of Leu56 (3.0 A) and a weak polar interaction with a carboxyl group of Asp58 (3.3 A), while the extracyclic moiety of the adenine ring interacts with the Asn60 side chain (3.5 A) 
where <I h > is the mean of the observations I ih of reflection h.
, where I i (hkl) are the observed intensities, <I(hkl)> are the average intensities and N is the multiplicity of reflection hkl.
/Σ|F p (obs)|; R free = R factor for a selected subset (5%) of the reflections that was not included in prior refinement calculations.
e Ramachandran plot calculated using MolProbity.
( Fig. 4A,B) . The adenine moiety is oriented in a hydrophobic environment consisting of Leu56, Ala84 and Ile86, while the side chain of Arg33 is oriented parallel to the adenine ring. The side chains of Arg11 and Arg33 form extensive charged interactions with the 2 0 -phosphate group of the 2 0 5 0 -ADP moiety together with Ser10. Ser10 and Arg11 both lie within the consensus GXXXGXG motif ( 8 GASRGIG 14 ) and confer specificity for NADP with Arg33. NADHdependent SDRs feature an aspartate residue that hydrogen bonds to the hydroxyl groups of the adenine ribose, which is replaced by Cys40 in Tx chicken fatty liver and Cys36 in D. melanogaster carbonyl reductases. PA4079 has an alanine (Ala32) in the equivalent position.
Interestingly, the backbone adenine phosphate (PA) of NADP shows different conformations in the two structures (Fig. 4A-C) . In the condition I structure, the backbone phosphate adopts an identical conformation to that observed in other carbonyl reductases and is most likely to represent the conformation in vivo (Figs 2 and 4A) . In this conformation, the phosphate is coordinated by the side chain of Arg11 and the loop containing the conserved GXXXGXG motif. In the condition II structure, NADP adopts an atypical conformation in which the backbone adenine phosphate moves by 2.9
A due to the presence of a sodium ion derived from the cocrystallization experiments (Fig. 4B,C) . The nicotinamide phosphate (PN) has the same conformation in both holo structures and is coordinated by the side chains of Asn83 (2.9
A via a water molecule positioned 2. 6 A from the phosphate group) and Thr186 (2.6 A), and by the main chain amide groups of Ile13 (3.0 A) and Gly14 (2.9 A via a water molecule positioned 2. 6 A from the phosphate group).
The highly conserved 'Ser-Tyr-Lys' catalytic triad of PA4079 is comprised of Ser135, Tyr151 and Lys155. The nicotinamide ribose of the NADP molecule is bound by the main chain carbonyl group of Asn83 and the side chains of Tyr151 (2.8 A) and Lys155 (3.0 A and 3.2 A) in the catalytic triad as well as by Thr186 (2.7 A). The nicotinamide moiety is further stabilized by interactions with Ser135, Gln136, His180, Pro181, Gly182 and Thr186.
Identification of the active site
Examination of the environment surrounding the cofactor in each NADP-bound complex structure identified additional electron density consistent with a small molecule. In the condition I structure, the additional electron density is modelled as an ethylene glycol molecule most likely derived from the crystallization conditions (Fig. 4A) . Ethylene glycol is coordinated by the NADP cofactor as well as by the side chains of residues Ser135 (2.8 A) and Gln136 (2.9 A). An ethylene glycol molecule observed in the TX chicken fatty liver CR structure is shifted by about 3 A relative to the position in PA4079 and instead interacts with Ser159 and Tyr178. This different mode of binding is unsurprising as Gln136 of PA4079 is nonconserved in Tx chicken fatty liver CR, substituted instead by Thr160 in the substrate-binding loop. In the condition II structure, the additional electron density is consistent with a nicotinamide molecule most likely derived from degradation of NADP added during cocrystallization (Fig. 4B) . The nicotinamide molecule stacks almost parallel against the pyridine ring of NADP and perpendicular to the catalytic Tyr151, and also forms hydrogen bonds with the side chains of the catalytic Ser135 (2.5 A) and Gln136 (2.9 A). The position of ethylene glycol and nicotinamide in the NADP-bound structures is occupied by the side chain of Trp183 in the apo structure, suggesting this residue may function as a 'lid' to regulate access to the active site and to help orient the substrate in the binding site ( Figs 4D and 5A) . Similar 'open' and 'closed' conformations have been observed for Tyr172 in the Tx chicken fatty liver carbonyl reductase, which opens by about 100°in the NADP-bound structure to accommodate an ethylene glycol molecule [22] . Tyr172 is nonconserved in PA4079 and forms part of an active site lid from Ile164 to Gln174 that reduces the available volume of the substrate-binding site. The equivalent region of PA4079 from Leu140 to Met148 forms a 3 10 helix that is quite distant from the binding pocket (Fig. 5B) . The positions of the ethylene glycol and nicotinamide molecules in the active site of PA4079 overlap with the position of the 3-(1-tert-butyl-4-amino-1H-pyrazolo [3,4-d] pyrimidin-3-yl)phenol (hydroxy-PP) substrate mimic in human carbonyl reductase 1, suggesting they mimic the position of the bound substrate (Fig. 5A ). The phenolic moiety of hydroxy-PP makes close contacts to Ser193 and Tyr139 of the catalytic triad and the bound NADP cofactor in human carbonyl reductase 1 [23] .
Comparison of apo-and holo-forms of PA4079 indicate that the loop from residues Pro181 to Ser196 becomes ordered upon NADP binding. In other CR enzymes, the equivalent loop functions as an active site specificity loop. The conformation of this active site specificity loop in PA4079 is similar to that observed in the structures of D. melanogaster carbonyl reductase Sniffer (residues Pro200 to Asp215) [21] , human carbonyl reductase 1 (residues Pro227 to Ser242) [23] and porcine carbonyl reductase 1 (residues Pro227 to Ser242) [24] (Figs 2B and 5A ). In contrast, Tx chicken fatty liver carbonyl reductase has a longer active site specificity loop from Pro208 to Thr226 with a markedly different structure to that of conventional carbonyl reductases, suggesting a more unique substrate-binding site [22] . This is reflected in the different enzymatic activities of the carbonyl reductases. PA4079, D. melanogaster Sniffer, human and porcine carbonyl reductases share efficient activity for 9,10-phenanthrenequinone but modest activity for p-nitrobenzaldehyde, whereas Tx chicken fatty liver carbonyl reductase has efficient activity for p-nitrobenzaldehyde but only modest activity for 9,10-phenanthrenequinone [22] . In addition to the conserved S-YXXK and GXXXGXG motifs characteristic of carbonyl reductases, multiple sequence alignment indicates that this active site specificity loop of carbonyl reductases contains a well-conserved PGWVXTXXXG motif that includes residues interacting with the nicotinamide moiety of NADP as well as the conserved tryptophan (Trp183 in PA4079) that functions as a putative active site lid (Fig. 3) .
To confirm the role of the active site residues, we constructed the catalytic triad mutants S135A, Y151F and K155M and assayed their activity for 9,10-phenanthrenequinone. We also constructed a W183A mutant corresponding to the active site 'lid' to investigate its role in substrate binding and activity. The results show that S135A, Y151F and K155M mutants have reduced activity for 9,10-phenanthrenequinone (Table 3 ). The W183A mutant has similar activity to the wild-type enzyme but with a 2.5-fold reduction in catalytic efficiency for 9,10-phenanthrenequinone as a substrate (Table 3) . No activity was detected for PA4079 mutants towards menadione or phenylglyoxal monohydrate as substrates (Fig. S2) . This confirms that Ser135, Tyr151 and Lys155 form part of the catalytic triad and suggests that the conserved Trp183 has a role in substrate binding.
Expression of pa4079 under stress from antibiotic exposure
The identification of P. aeruginosa PA4079 as a carbonyl reductase provides a starting point for understanding its substrate recognition and selectivity. Carbonyl reductases have a broad substrate spectrum that includes both endogenous and xenobiotic compounds [25] [26] [27] . Several drugs are also known to be substrates of carbonyl reductase enzymes, prompting Malatkova and Wsol to propose that carbonyl reduction be investigated as part of the drug development process for unintended effects (positive or negative) on drug efficacy [28] . Human carbonyl reductase 1, a close structural homologue of PA4079, is responsible for catalysis of several chemotherapy agents including daunorubicin [29] and doxorubicin [30, 31] , giving rise to drug resistance in cancer cells.
To elucidate the expression of the pa4079 gene under normal and stress conditions, we used qPCR with ciprofloxacin as a representative antibiotic. Under stress from ciprofloxacin exposure, the cellular membrane remained intact (Fig. 6A) . The qPCR results show that the normal expression level of pa4079 is high (Fig. 6B) . The expression level of pa4079 decreased at first exposure to the antibiotic and then increased to a higher level than the control sample after 1 h exposure (Fig. 6B) . The results suggest that pa4079 is a key housekeeping gene in P. aeruginosa PAO1 that plays an important role in the stress response to antibiotic exposure. Further work is underway to elucidate the roles of pa4079 in stress response or antibiotic resistance. 
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Fig. S1 . The asymmetric unit of apo PA4079 from (A) condition I and (B) condition II. Each asymmetric unit of apo PA4079 consists of four monomers, corresponding to two homodimers. Fig. S2 . Reduction of (A) menadione and (B) phenylglyoxal monohydrate by wild-type PA4079 and active site mutants. Key: black, control; red, wild-type; blue, Y151F; pink, K155M; green, W183A.
